Effects of a High‐Fat Meal on the Pharmacokinetics of Olverembatinib in Patients With Chronic Myeloid Leukemia

Documenti analoghi

• Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers
  di: Hengbang Wang, et al.
  Pubblicazione: (2024)
• Serum Haptoglobin as a Predictor of Treatment Response in Patients With Chronic Spontaneous Urticaria
  di: Kun‐Woo Park, et al.
  Pubblicazione: (2026)
• The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications
  di: Virginia D. Schmith, et al.
  Pubblicazione: (2026)
• Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug–Drug Interaction Study in Patients With Non‐Hodgkin Lymphoma
  di: Masaya Tachibana, et al.
  Pubblicazione: (2025)
• Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling of Serum M‐Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma
  di: Cheryl Li, et al.
  Pubblicazione: (2025)